The State of the Stent: Current Practices, Controversies, and Future Trends

References 

1. Sawa H, Vinogradsky B, Guala A, Fujii S. Genetically engineered endothelial cells: increased surface fibrinolysis and potential adaptation to endovascular stenting. Circulation. 1995;92(suppl I):1536
2. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation. 1995;91:2995–3001
   • MEDLINE
3. Goy JJ, Eeckhout E, Debbas N, Stauffer JC, Vogt P. Stenting of the right coronary artery for de novo stenosis. A comparison of the Wiktor and the Palmaz-Schatz stents. Circulation. 1995;92(suppl I):1596
4. Topol EJ. Caveats about elective coronary stenting. (Editorial.) N Engl J Med 1994;331:539–541.
5. Carrié D, Keane D, Elbaz M, Serruys PW, Puel J. Five year clinical and angiographic follow-up of the coronary Wallstent. Circulation. 1995;92(suppl I):I409
6. Debbas N, Sigwart U, Eeckhout E, Stauffer JC, Vogt P, Goy JJ. Late clinical follow-up 9 years after intracoronary stenting with the Wallstent. Circulation. 1995;92(suppl I):I280
7. Pietersma A, Kofflard M, de Wit LEA, Stijnen T, Koster JH, Serruys PW, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 1995;91:1320–1325
   • MEDLINE
8. DEBATE Study Group. . Doppler guide wire as a primary guide wire for PTCA. Feasibility, safety and continuous monitoring of the results. Circulation. 1995;92(suppl I):I263
9. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA, for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489–495.
10. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet MD, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA, on behalf of the Benestent-II Study Group. Heparin-coated Palmaz Schatz stents in human coronary arteries. Early outcome of the Benestent-II pilot study. Circulation 1996;93:412–422.
11. Isner JM, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease.. (News.) Circulation. 1995;91:2687–2692
    • MEDLINE